disease-modifying antirheumatic drug

'disease-modifying antirheumatic drug' can also refer to...

disease-modifying antirheumatic drug

disease-modifying antirheumatic drug

disease-modifying antirheumatic drug

disease-modifying antirheumatic drug n.

disease-modifying antirheumatic drug n.

disease-modifying antirheumatic drug n.

Disease-modifying anti-rheumatic drugs. Cyclosporin.

Adverse reactions to disease‐modifying anti‐rheumatic drugs in clinical practice

189. Disease-Modifying Antirheumatic Drugs Options for Myositis in UK Clinical Practice

I69 Guideline on Conventional Disease-Modifying Anti-Rheumatic Drugs


Influence of triple disease modifying anti-rheumatic drug therapy on carotid artery inflammation in drug-naive patients with recent onset of rheumatoid arthritis

BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids

Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab

Nonadherence to disease modifying antirheumatic drugs in the first year after diagnosis: comparing three adherence measures in early arthritis patients

105. Adherence to Disease-Modifying Anti-Rheumatic Drugs in Patients with Inflammatory Arthritis: A Survey of Patients Attending the Rheumatology Outpatients Department

E64 A Pilot Project on the Use of a Methotrexate Patient Information Film for Disease-Modifying Anti-Rheumatic Drug Counselling

168 Disease-Modifying Anti-Rheumatic Drug Prescribing by Clinical Commissioning Group: A Surrogate Marker for Service Activity

Short-term efficacy of etanercept plus methotrexate vs combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritis


More Like This

Show all results sharing this subject:

  • Medicine and Health


Show Summary Details

Quick Reference

(DMARD) any of various drugs used in the treatment of rheumatic disease: they affect the progression of the disease by suppressing the disease process. DMARDs include drugs affecting the immune response (immunomodulators), such as immunosuppressants (e.g. methotrexate) and cytokine inhibitors; gold salts; penicillamine; sulfasalazine; and hydroxychloroquine.

Subjects: Medicine and Health.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.